Boc-Lys(Ac)-OHCAS# 6404-26-8 |
- Cisplatin
Catalog No.:BCN1552
CAS No.:14283-03-5
- Z-VAD-FMK
Catalog No.:BCC1126
CAS No.:187389-52-2
- Z-WEHD-FMK
Catalog No.:BCC1139
CAS No.:210345-00-9
- Z-LEHD-FMK
Catalog No.:BCC5117
CAS No.:210345-04-3
- AZ 10417808
Catalog No.:BCC2356
CAS No.:331645-84-2
- Apoptosis Activator 2
Catalog No.:BCC2099
CAS No.:79183-19-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 6404-26-8 | SDF | Download SDF |
| PubChem ID | 7016049 | Appearance | Powder |
| Formula | C13H24N2O5 | M.Wt | 288.3 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S)-6-acetamido-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid | ||
| SMILES | CC(=O)NCCCCC(C(=O)O)NC(=O)OC(C)(C)C | ||
| Standard InChIKey | IOKOUUAPSRCSNT-JTQLQIEISA-N | ||
| Standard InChI | InChI=1S/C13H24N2O5/c1-9(16)14-8-6-5-7-10(11(17)18)15-12(19)20-13(2,3)4/h10H,5-8H2,1-4H3,(H,14,16)(H,15,19)(H,17,18)/t10-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Boc-Lys(Ac)-OH Dilution Calculator
Boc-Lys(Ac)-OH Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.4686 mL | 17.343 mL | 34.6861 mL | 69.3722 mL | 86.7152 mL |
| 5 mM | 0.6937 mL | 3.4686 mL | 6.9372 mL | 13.8744 mL | 17.343 mL |
| 10 mM | 0.3469 mL | 1.7343 mL | 3.4686 mL | 6.9372 mL | 8.6715 mL |
| 50 mM | 0.0694 mL | 0.3469 mL | 0.6937 mL | 1.3874 mL | 1.7343 mL |
| 100 mM | 0.0347 mL | 0.1734 mL | 0.3469 mL | 0.6937 mL | 0.8672 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Lys(Ac)-OH
- Torachrysone 8-O-glucoside
Catalog No.:BCN4181
CAS No.:64032-49-1
- 4(15)-Oppositene-1,7-diol
Catalog No.:BCN4180
CAS No.:640289-58-3
- Tamgermanetin
Catalog No.:BCN7944
CAS No.:640235-90-1
- Paroxetine maleate
Catalog No.:BCC7265
CAS No.:64006-44-6
- H-D-Val-OH
Catalog No.:BCC3145
CAS No.:640-68-6
- Etimizol
Catalog No.:BCC1562
CAS No.:64-99-3
- Colchicine
Catalog No.:BCN6271
CAS No.:64-86-8
- Tolbutamide
Catalog No.:BCC5001
CAS No.:64-77-7
- Tetracycline Hydrochloride
Catalog No.:BCC1206
CAS No.:64-75-5
- Demeclocycline hydrochloride
Catalog No.:BCC5303
CAS No.:64-73-3
- Physostigmine hemisulfate
Catalog No.:BCC6724
CAS No.:64-47-1
- Lobeline Hydrochloride
Catalog No.:BCC8202
CAS No.:63990-84-1
- Boc-Nle-OH
Catalog No.:BCC3296
CAS No.:6404-28-0
- Boc-ε-Acp-OH
Catalog No.:BCC3205
CAS No.:6404-29-1
- Z-D-Pro-OH
Catalog No.:BCC2752
CAS No.:6404-31-5
- Ro 04-5595 hydrochloride
Catalog No.:BCC7234
CAS No.:64047-73-0
- GANT 58
Catalog No.:BCC1587
CAS No.:64048-12-0
- Cannabispirol
Catalog No.:BCN4609
CAS No.:64052-90-0
- H-Ala(3-pyridyl)-OH.HCl
Catalog No.:BCC3321
CAS No.:64090-98-8
- Sennidin A
Catalog No.:BCN6354
CAS No.:641-12-3
- Alternariol
Catalog No.:BCN7147
CAS No.:641-38-3
- Allomatrine
Catalog No.:BCN2368
CAS No.:641-39-4
- 5-hydroxy-canthin-6-one
Catalog No.:BCN7910
CAS No.:64118-73-6
- Di-O-methylcrenatin
Catalog No.:BCN4608
CAS No.:64121-98-8
Synthesis of N(alpha)-Boc-N(epsilon)-tetrabenzyl-DTPA-L-lysine and N(alpha)-Fmoc-N(epsilon)-tetra-t-butyl-DTPA-L-lysine, building blocks for solid phase synthesis of DTPA-containing peptides.[Pubmed:12523643]
J Pept Sci. 2002 Dec;8(12):663-70.
Two building blocks, Boc-Lys(Bn4-DTPA)-OH and Fmoc-Lys(Bu4(t)-DTPA)-OH have been synthesized via the acylation of the epsilon-amino group of N(alpha)-protected lysine, using suitably protected tetra-esters of diethylene triamine pentaacetic acid (DTPA), a ligand with wide application as a chelating agent for complexing metal tons to peptides.
Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon.[Pubmed:18061431]
J Nutr Biochem. 2008 Sep;19(9):587-93.
Colorectal cancer is the most abundant cause of cancer mortality in the Western world. Nutrition and the microbial flora are considered to have a marked influence on the risk of colorectal cancer, the formation of butyrate and other short-chain fatty acids (SCFAs) possibly playing a major role as chemopreventive products of microbial fermentation in the colon. In this study, we investigated the effects of butyrate, other SCFAs, and of a number of phenolic SCFA and trans-cinnamic acid derivatives formed during the intestinal degradation of polyphenolic constituents of fruits and vegetables on global histone deacetylase (HDAC) activity in nuclear extracts from colon carcinoma cell cultures using tert-butoxycarbonyl-lysine (acetylated)-4-amino-7-methylcoumarin (Boc-Lys(Ac)-AMC) as substrate. Inhibition of HDAC activity, e.g., by butyrate, is related to a suppression of malignant transformation and a stimulation of apoptosis of precancerous colonic cells. In nuclear extracts from HT-29 human colon carcinoma cells, butyrate was found to be the most potent HDAC inhibitor (IC50=0.09 mM), while other SCFAs such as propionate were less potent. In the same assay, p-coumaric acid (IC50=0.19 mM), 3-(4-OH-phenyl)-propionate (IC50=0.62 mM) and caffeic acid (IC50=0.85 mM) were the most potent HDAC inhibitors among the polyphenol metabolites tested. Interestingly, butyrate was also the most potent HDAC inhibitor in a whole-cell HeLa Mad 38-based reporter gene assay, while all polyphenol metabolites and all other SCFAs tested were much less potent; some were completely inactive. The findings suggest that butyrate plays an outstanding role as endogenous HDAC inhibitor in the colon, and that other SCFAs and HDAC-inhibitory polyphenol metabolites present in the colon seem to play a much smaller role, probably because of their limited levels, their marked cytotoxicity and/or their limited intracellular availability.
